Zurück zum Inhalt

Onkologie

Multimodaler, interdisziplinärer und individualisierter Ansatz

Pancreaticoduodenectomy without homologous blood transfusion in an anemic Jehovah's Witness. (öffnet neues Fenster)

Atabek U, Spence RK, Pello M, Alexander J, Camishion R.

Quelle‎: Arch Surg 1992;127(3):349-51.

Indiziert‎: PubMed 1347993

https://www.ncbi.nlm.nih.gov/pubmed/1347993 (öffnet neues Fenster)

Complex liver resection for a large intrahepatic cholangiocarcinoma in a Jehovah's Witness: a strategy to avoid transfusion. (öffnet neues Fenster)

Barakat O, Cooper JR Jr, Riggs SA, Hoef JW, Ozaki CF, Wood RP.

Quelle‎: J Surg Oncol 2007;96(3):249-53.

Indiziert‎: PubMed 17443725

DOI‎: 10.1002/jso.20799

https://www.ncbi.nlm.nih.gov/pubmed/17443725 (öffnet neues Fenster)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (öffnet neues Fenster)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Quelle‎: Transfusion 2016;56(10):2438-42.

Indiziert‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (öffnet neues Fenster)

Impact of a patient blood management program and an outpatient anemia management protocol on red cell transfusions in oncology inpatients and outpatients. (öffnet neues Fenster)

Gross I, Trentino KM, Andreescu A, Pierson R, Maietta RA, Farmer S.

Quelle‎: Oncologist 2016;21(3):327-32.

Indiziert‎: PubMed 26865590

DOI‎: 10.1634/theoncologist.2015-0406

https://www.ncbi.nlm.nih.gov/pubmed/26865590 (öffnet neues Fenster)

Pancreas and liver resection in Jehovah's Witness patients: feasible and safe. (öffnet neues Fenster)

Konstantinidis IT, Allen PJ, D'Angelica MI, Dematteo RP, Fischer ME, Grant F, Fong Y, Kingham TP, Jarnagin WR.

Quelle‎: J Am Coll Surg 2013;217(6):1101-7.

Indiziert‎: PubMed 23880361

DOI‎: 10.1016/j.jamcollsurg.2013.05.020

https://www.ncbi.nlm.nih.gov/pubmed/23880361 (öffnet neues Fenster)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products. (öffnet neues Fenster)

Nguyen N, Madarang E, Alencar A, Watts J, Bradley T

Quelle‎: Leuk Res Rep. 2022 25;18:100355.

Indiziert‎: PubMed 36338830

DOI‎: 10.1016/j.lrr.2022.100355

https://pubmed.ncbi.nlm.nih.gov/36338830/ (öffnet neues Fenster)